Pulmonary pressure reduction attenuates expression of proteins identified by lung proteomic profiling in pulmonary hypertensive rats

Proteomics

Volumn 11, Issue 23, 2011, Pages 4492-4502

  Østergaard, Louise ^a   Honoré, Bent ^a   Thorsen, Lise B ^a   Baandrup, Jonas ^a   Eskildsen Helmond, Yvonne ^a   Laursen, Britt E ^a   Vorum, Henrik ^b   Mulvany, Michael J ^a   Simonsen, Ulf ^a  

^a AARHUS UNIVERSITY   (Denmark)

^b AALBORG UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Animal proteomics; Hypoxia; Muscularization; Pulmonary hypertension; Sildenafil

Indexed keywords

4 AMINO 5 CYCLOPROPYL 2 [1 (2 FLUOROBENZYL) 1H PYRAZOLO[3,4 B]PYRIDIN 3 YL]PYRIMIDINE; CATHEPSIN D; ELONGATION FACTOR 1DELTA; F ACTIN; GLUTATHIONE TRANSFERASE; GUANINE NUCLEOTIDE BINDING PROTEIN BETA SUBUNIT; LIPOCORTIN 4; PROTEIN CAPZ; PROTEOME; SILDENAFIL; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; GENE EXPRESSION PROFILING; HYPOXIA; IMMUNOBLOTTING; LUNG HOMOGENATE; LUNG PRESSURE; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PULMONARY ARTERY; PULMONARY HYPERTENSION; RAT; SIGNAL TRANSDUCTION; SYSTOLIC BLOOD PRESSURE; UPREGULATION;

AMINO ACID SEQUENCE; ANIMALS; ANOXIA; GENE EXPRESSION REGULATION; GUANYLATE CYCLASE; HEMODYNAMICS; HYPERTENSION, PULMONARY; LUNG; MALE; MOLECULAR SEQUENCE DATA; PHOSPHODIESTERASE 5 INHIBITORS; PIPERAZINES; PROTEOME; PROTEOMICS; PURINES; PYRAZOLES; PYRIDINES; RATS; RATS, WISTAR; SIGNAL TRANSDUCTION; SULFONES;

EID: 81855185409     PISSN: 16159853     EISSN: 16159861     Source Type: Journal    
DOI: 10.1002/pmic.201100171     Document Type: Article

References (31)

1. Tuder, R. M., Marecki, J. C., Richter, A., Fijalkowska, I., Flores, S., Pathology of pulmonary hypertension. Clin. Chest Med. 2007, 28, 23-42.
2. Stenmark, K. R., Fagan, K. A., Frid, M. G., Hypoxia-induced pulmonary vascular remodeling: cellular and molecular mechanisms. Circ. Res. 2006, 99, 675-691.
3. Newman, J. H., Trembath, R. C., Morse, J. A., Grunig, E., et al., Genetic basis of pulmonary arterial hypertension: current understanding and future directions. J. Am. Coll. Cardiol. 2004, 43, 33S-39S.
4. Takahashi, H., Goto, N., Kojima, Y., Tsuda, Y., et al., Downregulation of type II bone morphogenetic protein receptor in hypoxic pulmonary hypertension. Am. J. Physiol. Lung Cell Mol. Physiol. 2006, 290, L450-L458.
5. Archer, S., Rich, S., Primary pulmonary hypertension: a vascular biology and translational research "Work in progress". Circulation 2000, 102, 2781-2791.
6. Strange, J. W., Wharton, J., Phillips, P. G., Wilkins, M. R., Recent insights into the pathogenesis and therapeutics of pulmonary hypertension. Clin. Sci. (Lond.) 2002, 102, 253-268.
7. Weir, E. K., Olschewski, A., Role of ion channels in acute and chronic responses of the pulmonary vasculature to hypoxia. Cardiovasc. Res. 2006, 71, 630-641.
8. Kwapiszewska, G., Wilhelm, J., Wolff, S., Laumanns, I., et al., Expression profiling of laser-microdissected intrapulmonary arteries in hypoxia-induced pulmonary hypertension. Respir. Res. 2005, 6, 109.
9. Laudi, S., Steudel, W., Jonscher, K., Schoning, W., et al., Comparison of lung proteome profiles in two rodent models of pulmonary arterial hypertension. Proteomics 2007, 7, 2469-2478.
10. Bader, M., Rat models of cardiovascular diseases. Methods Mol. Biol. 2010, 597, 403-414.
11. Meyrick, B., Reid, L., Hypoxia-induced structural changes in the media and adventitia of the rat hilar pulmonary artery and their regression. Am. J. Pathol. 1980, 100, 151-178.
12. Elmedal, B., de Dam, M. Y., Mulvany, M. J., Simonsen, U., The superoxide dismutase mimetic, tempol, blunts right ventricular hypertrophy in chronic hypoxic rats. Br. J. Pharmacol. 2004, 141, 105-113.
13. Thorsen, L. B., Eskildsen-Helmond, Y., Zibrandtsen, H., Stasch, J. P., et al., BAY 41-2272 inhibits the development of chronic hypoxic pulmonary hypertension in rats. Eur. J. Pharmacol. 2010, 647, 147-154.
14. Baandrup, J., Markvadsen, L. H., Peters, C. D., Schou, U. K. et al., Pressure load: The main factor for altered gene expression in right ventricular hypertrophy in chronic hypoxic rats. PLoS One 2011, 6, e15859.
15. Ostergaard, M., Hansen, G. A., Vorum, H., Honore, B., Proteomic profiling of fibroblasts reveals a modulating effect of extracellular calumenin on the organization of the actin cytoskeleton. Proteomics 2006, 6, 3509-3519.
16. Perkins, D. N., Pappin, D. J., Creasy, D. M., Cottrell, J. S., Probability-based protein identification by searching sequence databases using mass spectrometry data. Electrophoresis 1999, 20, 3551-3567.
17. Barsnes, H., Vizcaino, J. A., Eidhammer, I., Martens, L., PRIDE Converter: making proteomics data-sharing easy. Nat. Biotechnol. 2009, 27, 598-599.
18. Vizcaino, J. A., Cote, R., Reisinger, F., Foster, J. M. et al., A guide to the Proteomics Identifications Database proteomics data repository. Proteomics 2009, 9, 4276-4283.
19. Ostergaard, L., Stankevicius, E., Andersen, M. R., Eskildsen-Helmond, Y. et al., Diminished NO release in chronic hypoxic human endothelial cells. Am. J. Physiol. Heart Circ. Physiol. 2007, 293, H2894-H2903.
20. Hayes, J. D., Flanagan, J. U., Jowsey, I. R., Glutathione transferases. Annu. Rev. Pharmacol. Toxicol. 2005, 45, 51-88.
21. Hayes, J. D., Pulford, D. J., The glutathione S-transferase supergene family: regulation of GST and the contribution of the isoenzymes to cancer chemoprotection and drug resistance. Crit. Rev. Biochem. Mol. Biol. 1995, 30, 445-600.
22. Ong, L. L., Er, C. P., Ho, A., Aung, M. T., Yu, H., Kinectin anchors the translation elongation factor-1 delta to the endoplasmic reticulum. J. Biol. Chem. 2003, 278, 32115-32123.
23. Liaudet-Coopman, E., Beaujouin, M., Derocq, D., Garcia, M. et al., Cathepsin D: newly discovered functions of a long-standing aspartic protease in cancer and apoptosis. Cancer Lett. 2006, 237, 167-179.
24. McGregor, E., Kempster, L., Wait, R., Gosling, M. et al., F-actin capping (CapZ) and other contractile saphenous vein smooth muscle proteins are altered by hemodynamic stress: a proteonomic approach. Mol. Cell. Proteomics 2004, 3, 115-124.
25. Gerke, V., Moss, S. E., Annexins: from structure to function. Physiol. Rev. 2002, 82, 331-371.
26. Hill, W. G., Kaetzel, M. A., Kishore, B. K., Dedman, J. R., Zeidel, M. L., Annexin A4 reduces water and proton permeability of model membranes but does not alter aquaporin 2-mediated water transport in isolated endosomes. J. Gen. Physiol. 2003, 121, 413-425.
27. Berryman, M., Bruno, J., Price, J., Edwards, J. C., CLIC-5A functions as a chloride channel in vitro and associates with the cortical actin cytoskeleton in vitro and in vivo. J. Biol. Chem. 2004, 279, 34794-34801.
28. Koglin, M., Stasch, J. P., Behrends, S., BAY 41-2272 activates two isoforms of nitric oxide-sensitive guanylyl cyclase. Biochem. Biophys. Res. Commun. 2002, 292, 1057-1062.
29. Stasch, J. P., Becker, E. M., onso-Alija, C., Apeler, H. et al., NO-independent regulatory site on soluble guanylate cyclase. Nature 2001, 410, 212-215.
30. Humbert, M., Sitbon, O., Simonneau, G., Treatment of pulmonary arterial hypertension. N. Engl. J. Med. 2004, 351, 1425-1436.
31. Kanthapillai, P., Lasserson, T., Walters, E., Sildenafil for pulmonary hypertension. Cochrane Database Syst. Rev. 2004, 4, CD003562.